Paper Details 
Original Abstract of the Article :
Experimental and clinical studies suggest that the low-affinity N-methyl-d-aspartate (NMDA) receptor open-channel blockers Mg<sup>2+</sup> and memantine are effective in reducing trigeminal nociceptive activation. The aim of this study was to investigate the apparent effectiveness of these channel b...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/31009120

データ提供:米国国立医学図書館(NLM)

Memantine and Magnesium: Potential Headache Relief Through NMDA Receptor Modulation

Headaches, particularly migraines, are a common and often debilitating condition. This study investigated the potential of memantine and magnesium, NMDA receptor open-channel blockers, in reducing trigeminal nociceptive activation, a key mechanism involved in headache pain. The researchers conducted experiments to assess the effects of these drugs on trigeminal nerve activity in rats.

Memantine and Magnesium: Effective in Reducing Trigeminal Nociceptive Activation

The study found that both memantine and magnesium effectively inhibited mechanically and electrically stimulated craniovascular afferents, suggesting their potential to reduce headache pain. However, the effects were only observed when these drugs were applied locally. Systemic administration of memantine and magnesium did not significantly affect trigeminal nerve activity. The study highlights the need for further research to explore alternative delivery methods or investigate other NMDA receptor modulators for effective headache treatment.

Targeting NMDA Receptors: A New Approach to Headache Management

This study provides evidence for the potential of NMDA receptor modulation as a novel approach to headache treatment. While memantine and magnesium showed promising results in reducing trigeminal nociceptive activation, further research is needed to develop effective delivery methods for these drugs or explore other NMDA receptor modulators to optimize their therapeutic potential in treating headaches.

Dr. Camel's Conclusion

This research provides valuable insights into the potential of memantine and magnesium, NMDA receptor open-channel blockers, in reducing headache pain. While the study demonstrated effectiveness when these drugs were applied locally, further research is needed to develop effective delivery methods or explore other NMDA receptor modulators for optimal therapeutic efficacy. It opens new avenues for exploring innovative approaches to managing headaches and alleviating pain for those suffering from this common condition.

Date :
  1. Date Completed 2020-08-10
  2. Date Revised 2022-10-05
Further Info :

Pubmed ID

31009120

DOI: Digital Object Identifier

EMS128034

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.